Medispec Ltd.


Therapeutic Area(s):
Cardiovascular, Nephrology, Orthopedic, Urology, Veterinary, Wound Management
Company Status:
Revenue Growth

Company at a Glance

With over 25 years of experience and expertise in shockwave therapy solutions, Medispec continuously introduces competitive systems and technological breakthroughs to the market. The company specializes in shockwave-based systems for urology, cardiovascular and orthopedics applications. Medispec services clinics, medical centers and hospitals in over 80 countries worldwide. All of the company’s systems offer modular design, versatility, ease of use and high degree of mobility, for delivering innovative technology in a fast and efficient manner.

We aspire to bring the opportunity to heal wherever it is needed. Our professional team continuously innovates and explores new medical applications where shockwave therapy can be used to heal and better people’s lives across the globe.

Technology & Product(s)

Shockwave therapy offers an alternative to surgery and its undesirable side effects. We offer non- invasive treatment with proven high success rates, as well as drugs- free and painless treatment at short treatment time.

Our flagship device- ED1000- offers gold standard treatment for Erectile Dysfunction.

Erectile Dysfunction Shock Wave Therapy (EDSWT) is an innovative approach to vasculogenic ED, using advanced acoustics technology.

EDSWT utilizes low-intensity extracorporeal shock waves, focusing on blood vessels and encouraging neovascularization in the penis shaft and crus. The low-intensity shock waves help relieve vascular deficiency, a common cause of erectile dysfunction.

The shock wave treatment causes no side-effects or systemic load on other organs and healthy tissues. This non-invasive, painless EDSWT procedure is performed during a series of brief visits to the urology office, and requires no sedation or anesthesia.

Cardiospec- New non-invasive therapy approach using Extracorporeal Shockwave for Myocardial Revascularization (ESMR) offers non-invasive therapy, clinically proven and safe procedure, which stimulates the formation of collateral blood vessels in ischemic heart tissue, enhances blood perfusion and restores cardiac function. Cardiospec is the only system in the market offering the largest focal zone and a unique precision ultrasound probe enabling accurate targeting.

Goals

Objectives: Expending our business partners and distributors
Target businesses: To expend our distributers channels, as well as hospitals and medical centers
Target Countries: Germany, Switzerland, Austria, Belgium ,Sweden, Slovakia Hungary, Romania, Bulgaria, Poland, Czech, Ukraine, Russia, Baltics , India, China, S. Korea, Thailand , Vietnam, Philippines, Hong Kong, Turkey, S. Africa